Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Autoimmune Diseases
>>
Tyrosine Kinase Inhibitors
>>
Phase 2
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Kinaction
(masitinib) / AB Science
decernotinib
(VX-509) / Vertex
Aspart-PH20
(insulin aspart/rHuPH20) / Halozyme
Jyseleca
(filgotinib) / Galapagos, Gilead, SOBI
SB-509
/ Biogen
oral insulin
(ORMD-0801) / Oramed
Jakafi
(ruxolitinib) / Incyte
MK-8457
/ Merck (MSD)
PRT062607
/ Biogen, AstraZeneca
R 333
/ Rigel
SAR 161271
/ Sanofi
Smyraf
(peficitinib) / Astellas, Maruho
everolimus
/ Generic mfg.
imatinib
/ Generic mfg.
itacitinib
(INCB039110) / Incyte
ultra-rapid-acting recombinant human insulin
(BIOD-123) / Ipsen
